Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added. Several glossary/related items were removed, including Non-alcoholic fatty liver disease, MedlinePlus Genetics, and Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T07:12:10.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added related topics: Nonalcoholic fatty liver disease and MedlinePlus Genetics to the study page.
    Difference
    0.0%
    Check dated 2026-03-13T01:30:12.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-05T19:50:52.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Removed the related-topics metadata entries for 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics'. These tags are auxiliary and do not alter the primary study information.
    Difference
    0.0%
    Check dated 2026-02-19T05:27:50.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Added Non-alcoholic fatty liver disease and related topics (including MedlinePlus Genetics) and updated the site revision to v3.4.2; removed the government funding lapse notice (and the prior v3.4.1 revision). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T02:27:54.000Z thumbnail image
  9. Check
    70 days ago
    Change Detected
    Summary
    A government funding notice banner was added and the page revision version updated. A non-critical glossary term related to nonalcoholic fatty liver disease was removed.
    Difference
    0.2%
    Check dated 2026-02-03T23:35:04.000Z thumbnail image

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.